Italy: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
The EU Pharma Package Is Finally Here – Here's The Settled Position On Key Areas
The EU Pharma Package introduces the most comprehensive reform of European pharmaceutical legislation in over two decades, fundamentally restructuring regulatory data protection, market exclusivity periods, and orphan drug incentives. With political agreement reached and formal adoption imminent, pharmaceutical companies face significant changes to data protection frameworks, supply obligations, and the expanded Bolar exemption that will reshape competitive dynamics across the European medicines market.
European Union Healthcare
KL
Herbert Smith Freehills Kramer LLP
See more

Food and Drugs Law

Article
The End Of Animal Testing? The EU’s Chemical Safety Plan Explained
The European Commission has published a comprehensive roadmap to phase out animal testing for chemical safety assessments by 2026, outlining 22 concrete actions across 15 legislative domains. While the communication itself is non-binding, it signals significant regulatory changes ahead that will reshape data requirements, testing strategies, and compliance obligations for businesses operating in pharmaceuticals, chemicals, and related sectors.
European Union Government
SR
McDermott Will & Schulte
Article
The EU Pharma Package Is Finally Here – Here's The Settled Position On Key Areas
The EU Pharma Package introduces the most comprehensive reform of European pharmaceutical legislation in over two decades, fundamentally restructuring regulatory data protection, market exclusivity periods, and orphan drug incentives. With political agreement reached and formal adoption imminent, pharmaceutical companies face significant changes to data protection frameworks, supply obligations, and the expanded Bolar exemption that will reshape competitive dynamics across the European medicines market.
European Union Healthcare
KL
Herbert Smith Freehills Kramer LLP
See more

Life Sciences, Biotechnology & Nanotechnology

Article
The EU Pharma Package Is Finally Here – Here's The Settled Position On Key Areas
The EU Pharma Package introduces the most comprehensive reform of European pharmaceutical legislation in over two decades, fundamentally restructuring regulatory data protection, market exclusivity periods, and orphan drug incentives. With political agreement reached and formal adoption imminent, pharmaceutical companies face significant changes to data protection frameworks, supply obligations, and the expanded Bolar exemption that will reshape competitive dynamics across the European medicines market.
European Union Healthcare
KL
Herbert Smith Freehills Kramer LLP
See more

Healthcare

Article
The EU Pharma Package Is Finally Here – Here's The Settled Position On Key Areas
The EU Pharma Package introduces the most comprehensive reform of European pharmaceutical legislation in over two decades, fundamentally restructuring regulatory data protection, market exclusivity periods, and orphan drug incentives. With political agreement reached and formal adoption imminent, pharmaceutical companies face significant changes to data protection frameworks, supply obligations, and the expanded Bolar exemption that will reshape competitive dynamics across the European medicines market.
European Union Healthcare
KL
Herbert Smith Freehills Kramer LLP
See more

Latest Videos

See more